Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.54 USD | -1.40% | +10.66% | +15.44% |
May. 09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Phathom Pharmaceuticals, Inc.
Upcoming events on Phathom Pharmaceuticals, Inc.
Past events on Phathom Pharmaceuticals, Inc.
Today 06:00 pm | Digestive Disease Week Conference |
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 08:00 am | Q1 2024 Earnings Release |
2024-04-10 09:30 am | Needham Healthcare Conference |
2024-03-07 08:30 am | Q4 2023 Earnings Call |
2024-03-07 08:00 am | Q4 2023 Earnings Release |
2024-02-07 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
2023-11-29 04:15 pm | Evercore ISI HealthCONx Conference |
2023-11-15 | Craig-Hallum Alpha Select Conference |
2023-11-15 02:25 pm | Stifel Healthcare Conference |
2023-11-14 10:30 am | Jefferies London Healthcare Conference |
2023-11-09 08:00 am | Q3 2023 Earnings Release |
2023-11-07 02:30 pm | Guggenheim Securities Inflammation & Immunology Conference |
2023-11-02 11:00 am | PHALCON-EE Phase 3 Trial Results Call |
2023-09-13 02:30 pm | H.C. Wainwright Global Investment Conference |
2023-09-11 | Morgan Stanley Global Healthcare Conference |
2023-08-10 08:01 am | Q2 2023 Earnings Release |
2023-06-14 11:00 am | Goldman Sachs Global Healthcare Conference |
2023-06-07 01:30 pm | Jefferies Global Healthcare Conference |
2023-05-25 11:30 am | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,68 0,44 55.12% | 42,2 |
EBITDA Million USD | Released Forecast Spread | -106 -118 10.05% | -125 -105 -19.44% | -135 -137 1.91% | -172 -165 -4.44% | -167 -162 -3.01% | -262 |
EBIT Million USD | Released Forecast Spread | -106 -84,9 -25.08% | -126 -105 -19.3% | -135 -139 2.93% | -172 -173 0.23% | -167 -152 -10.29% | -267 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -255 -112 -127.95% | -129 -108 -19.62% | -144 -143 -0.53% | -198 -196 -0.64% | -202 -186 -8.36% | -318 |
Net income Million USD | Released Forecast Spread | -255 -112 -127.95% | -129 -108 -19.66% | -144 -145 0.98% | -198 -196 -0.66% | -202 -186 -8.36% | -318 |
EPS USD | Released Forecast Spread | -11,4 -10,4 -9.38% | -3,88 -3,44 -12.79% | -3,89 -3,93 1.07% | -5,05 -5,01 -0.8% | -3,93 -3,79 -3.79% | -5,25 |
Announcement Date | 19/03/20 | 30/03/21 | 01/03/22 | 28/02/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,16 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,68 0,38 79.85% | 1,91 2,14 -10.7% | 5,55 | 11,3 | 22,9 | 29,0 | 42,2 |
EBITDA Million USD | Released Forecast Spread | -62,7 | -61,0 | -56,8 | |||||||||||
EBIT Million USD | Released Forecast Spread | -37,9 -35,3 -7.29% | -45,4 -39,6 -14.68% | -42,5 -46,4 8.31% | -46,6 -46,6 -0.08% | -30,1 -46,1 34.77% | -31,7 -38,8 18.24% | -35,7 -40,9 12.75% | -69,9 -57,8 -20.8% | -70,0 -62,5 -11.95% | -70,0 | -68,2 | -61,9 | -59,7 | -49,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -40,7 -37,7 -7.79% | -50,9 -42,7 -19.25% | -51,1 -49,6 -3.01% | -55,0 -51,2 -7.51% | -37,8 -50,5 25.07% | -41,0 -43,5 5.81% | -43,2 -48,1 10.09% | -79,6 -62,3 -27.75% | -82,9 -69,7 -18.85% | -78,2 | -76,1 | -68,9 | -67,8 | -61,9 |
Net income Million USD | Released Forecast Spread | -40,7 -37,7 -7.79% | -50,9 -42,7 -19.25% | -51,1 -49,6 -3.01% | -55,0 -51,2 -7.51% | -37,8 -50,5 25.07% | -41,0 -43,5 5.81% | -43,2 -48,1 10.09% | -79,6 -62,3 -27.75% | -82,9 -69,7 -18.85% | -78,2 | -76,1 | -68,9 | -67,8 | -61,9 |
EPS USD | Released Forecast Spread | -1,07 -0,97 -10.54% | -1,33 -1,03 -29.13% | -1,32 -1,32 0.15% | -1,33 -1,34 1.04% | -0,89 -1,25 28.8% | -0,84 -0,98 14.11% | -0,76 -0,90 15.24% | -1,39 -1,11 -24.85% | -1,42 -1,29 -10.32% | -1,40 | -1,37 | -1,11 | -1,08 | -1,06 |
Announcement Date | 10/05/22 | 02/08/22 | 08/11/22 | 28/02/23 | 10/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | 09/05/24 | - | - | - | - | - |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Phathom Pharmaceuticals, Inc.
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHAT Stock
- Calendar Phathom Pharmaceuticals, Inc.